Optimizing the use of prescription drugs in Canada through the Common Drug Review
CMAJ
.
2008 Feb 12;178(4):432-5.
doi: 10.1503/cmaj.070713.
Authors
Mike Tierney
1
,
Braden Manns
;
Members of the Canadian Expert Drug Advisory Committee
Affiliation
1
Common Drug Review, Canadian Agency for Drugs and Technologies in Health, Ottawa, Ont.
PMID:
18268271
PMCID:
PMC2228339
DOI:
10.1503/cmaj.070713
No abstract available
Publication types
Review
MeSH terms
Canada
Cost-Benefit Analysis
Drug Costs / standards*
Drug Prescriptions / standards*
Drug Utilization Review / methods*
Humans